karalex pharma

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

 		karalex pharma
home about karalex products team news contact us
empty


On July 2, 2010, Karalex Pharma was acquired by OrchidPharma, Inc. (a Subsidiary of Orchid Chemicals & Pharmaceuticals Ltd.) and is proud to now be its front-end sales & marketing organization in the United States & Canada.
empty

 

 

    

Karalex Pharma is leading the way as a provider of generic pharmaceuticals focused exclusively on the US healthcare market.

Our commitment to providing cost effective, quality pharmaceutical products is backed by our relationships in the industry and enhanced by our extensive expertise in marketing and sales services. And with our innovative vision and respected experience, we make it happen.
Karalex Pharma
Performance.

Jointly, the principals of Karalex Pharma have launched over 100 generic pharmaceutical products with combined value in excess of $1 billion dollars. Renowned for their extensive experience, they excel in the identification, in-licensing, and strategic positioning of critical generic product opportunities within the pharmaceutical industry.
Karalex Pharma
Integrity.

Karalex Pharma has tactically positioned itself to take advantage of the present dynamic marketplace. Its executive generic pharmaceutical sales and marketing experts have sustained long-term relationships within the pharmaceutical supply chain due to the respectability of their business dealings and their high ethical standards.
Karalex Pharma
Leadership.

As a US generic pharmaceutical company exclusively focused on the needs of our customers and development / manufacturing partners, Karalex Pharma's commitment to performance showcases fresh, innovative answers for providing cost-effective pharmaceuticals.
   
 
   

©2010 Karalex Pharma (a subsidiary of Orchid Chemicals & Pharmaceuticals),
700 Alexander Park, Suite 104, Princeton NJ 08540 All Rights Reserved		 Compliance Program | Privacy Policy